Ivan David HorakFounder & CEO at Tikva Allocell Pte LtdPresenter
Profile
At Tikva Allocell, our mission is to develop safe, effective, readily available and affordable “off-the-shelf” T cell therapies by leveraging excellent safety profile of ALLO EBVST and proprietary technologies that enhance the T cell's performance to treat cancer and autoimmune diseases.
Agenda Sessions
Immuno-Oncology: Tikva Allocell Pte Ltd
, 11:15View Session